Company to Develop Thin Film Version of BioBacksheet Due to Growing Interest From Thin Film Solar Manufacturers

BioSolar, Inc. (OTCBB:BSRC), developer of a breakthrough technology to produce bio-based materials from renewable plant sources that reduce the cost of photovoltaic solar modules, today announced its plan to expand the company's BioBacksheet™ technology to accommodate copper-indium-gallium-selenide (CIGS) and cadmium telluride (CdTe) thin-film modules.

Currently, the company’s patent-pending BioBacksheet™ technology for crystalline silicon (C-Si) photovoltaic solar cells is in the pre-production phase. Designed to replace petroleum-based components with renewable plant sources, the BioBacksheet™ is a premium-grade backsheet consisting of a cellulosic film combined with a highly water resistant and high dielectric strength nylon film made from castor beans.

“At present, the C-Si area is the largest photovoltaic market segment,” said Dr. David Lee, BioSolar chairman and CEO. “However, at BioSolar we recognize that the low-cost potential of thin-film modules, particularly CIGS and CdTe, are emerging as formidable competitors in the global solar market and attracting gigantic investments. Many of these thin film PV manufacturers have expressed strong interests for a “green” backsheet to be incorporated into their thin-film solar panels.”

In a new solar report forecasting production and comparing technologies, "PV Technology, Production and Cost, 2009 Forecast,” Greentech Media analysts report that “companies making cadmium-telluride panels could produce nearly 1.5 gigawatts, or 6 percent, of the global supply by 2012.” The report also said that in the same time frame, “companies that make copper-indium-gallium-selenide solar panels could produce 12 percent, or nearly 3 gigawatts, of the worldwide supply of solar panels.”

“These products require a backsheet comprising an almost perfect moisture barrier,” said Dr. Stanley Levy, BioSolar’s Chief Technology Officer. “Currently, glass is the material of choice. It works, but it is heavy and expensive. In response, we have started development on a BioBacksheet with the required barrier properties for this application. It is a composite film consisting of bio-based and 100% recyclable materials. The resulting product is expected to be much lighter than glass as well as lower cost.”

“The greatest impediment to solar replacing fossil fuels is cost,” said Lee. “Manufacturers struggling to make these technologies cost-effective are increasingly looking to various material choices. We expect this breakthrough product to be rapidly adopted as the standard for the backsheet component of both traditional as well as thin-film photovoltaic modules.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BioSolar. (2019, February 14). Company to Develop Thin Film Version of BioBacksheet Due to Growing Interest From Thin Film Solar Manufacturers. AZoNano. Retrieved on April 16, 2024 from https://www.azonano.com/news.aspx?newsID=10283.

  • MLA

    BioSolar. "Company to Develop Thin Film Version of BioBacksheet Due to Growing Interest From Thin Film Solar Manufacturers". AZoNano. 16 April 2024. <https://www.azonano.com/news.aspx?newsID=10283>.

  • Chicago

    BioSolar. "Company to Develop Thin Film Version of BioBacksheet Due to Growing Interest From Thin Film Solar Manufacturers". AZoNano. https://www.azonano.com/news.aspx?newsID=10283. (accessed April 16, 2024).

  • Harvard

    BioSolar. 2019. Company to Develop Thin Film Version of BioBacksheet Due to Growing Interest From Thin Film Solar Manufacturers. AZoNano, viewed 16 April 2024, https://www.azonano.com/news.aspx?newsID=10283.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.